| Kaplan-Meier | Cox Regression Analysis |
---|
 | Significance | Significance | Exp(B) | CI |
---|
ICAMa
| Â | Â | Â | Â |
<771 ng/ml | 0.009** | 0.021* | 1 | Â |
771- 1127 ng/ml | Â | Â | 2.39 | 1.22, 4.70 |
>1127 ng/ml | Â | Â | 2.38 | 1.24, 4.59 |
ICAMb
| Â | Â | Â | Â |
<771 ng/ml | 0.009** | 0.037* | 1 | Â |
771- 1127 ng/ml | Â | Â | 2.04 | 1.02, 4.06 |
>1127 ng/ml | Â | Â | 2.37 | 1.22, 4.61 |
ICAMc
| Â | Â | Â | Â |
<771 ng/ml | 0.009** | 0.021* | 1 | Â |
771- 1127 ng/ml | Â | Â | 2.39 | 1.22, 4.70 |
>1127 ng/ml | Â | Â | 2.30 | 1.22, 4.57 |
- Levels of significance (* p < 0.05, ** p < 0.01).
-
aCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol and HDL cholesterol.
-
bCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, eGFR and hsCRP.
-
cCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, eGFR, hsCRP and history of vascular disease at enrolment.